1
2
Douma, Renée A., Le Gal, Grégoire, Söhne, Maaike, Righini, Marc, Kamphuisen, Pieter W., Perrier, Arnaud, Kruip, Marieke J. H. A., Bounameaux, Henri, Büller, Harry R., Roy, Pierre-Marie
Veröffentlicht in: Douma , R A , Le Gal , G , Söhne , M , Righini , M , Kamphuisen , P W , Perrier , A , Kruip , M J H A , Bounameaux , H , Büller , H R & Roy , P-M 2010 , ' Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: A retrospective analysis of three large cohorts ' , British Medical Journal , vol. 340 , no. 7753 , c1475 , pp. 962 . https://doi.org/10.1136/bmj.c1475;
2010
Veröffentlicht in: Douma , R A , Le Gal , G , Söhne , M , Righini , M , Kamphuisen , P W , Perrier , A , Kruip , M J H A , Bounameaux , H , Büller , H R & Roy , P-M 2010 , ' Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: A retrospective analysis of three large cohorts ' , British Medical Journal , vol. 340 , no. 7753 , c1475 , pp. 962 . https://doi.org/10.1136/bmj.c1475;
2010
3
4
5
6
7
de Jong, Josta, Bos, Jens H J, de Vries, Tjalling W, de Jong-van den Berg, Lolkje T W
Veröffentlicht in: de Jong , J , Bos , J H J , de Vries , T W & de Jong-van den Berg , L T W 2012 , ' Antibiotic use in children and the use of medicines by parents ' , Archives of Disease in Childhood , vol. 97 , no. 6 , pp. 578-581 . https://doi.org/10.1136/archdischild-2011-301150;
2012
Veröffentlicht in: de Jong , J , Bos , J H J , de Vries , T W & de Jong-van den Berg , L T W 2012 , ' Antibiotic use in children and the use of medicines by parents ' , Archives of Disease in Childhood , vol. 97 , no. 6 , pp. 578-581 . https://doi.org/10.1136/archdischild-2011-301150;
2012
8
9
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
10